A2M

alpha-2-macroglobulin, the group of Alpha-2-macroglobulin family

Basic information

Region (hg38): 12:9067664-9116229

Links

ENSG00000175899NCBI:2OMIM:103950HGNC:7Uniprot:P01023AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Alzheimer disease type 1 (No Known Disease Relationship), mode of inheritance: Unknown

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Alpha-2-macroglobulin deficiencyADGeneralThe clinical consequences of variants are unclearGeneral94459; 2475424; 1370808
Variants have been implicated in pulmonary disease, but the evidence appears mixed

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the A2M gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the A2M gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
8
clinvar
7
clinvar
15
missense
58
clinvar
9
clinvar
5
clinvar
72
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
2
2
non coding
2
clinvar
2
Total 0 0 58 19 13

Variants in A2M

This is a list of pathogenic ClinVar variants found in the A2M region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
12-9068192-A-C not specified Uncertain significance (Aug 30, 2021)2247316
12-9068742-G-A not specified Uncertain significance (Dec 05, 2022)2205638
12-9068842-C-T not specified Uncertain significance (Dec 06, 2021)2265103
12-9069776-C-T not specified Uncertain significance (Jun 22, 2024)3266898
12-9069803-G-C not specified Uncertain significance (Dec 17, 2023)3080278
12-9069804-A-C not specified Uncertain significance (Aug 22, 2023)2620624
12-9070564-C-T not specified Uncertain significance (Dec 30, 2023)3079719
12-9072396-T-C not specified Uncertain significance (Jul 26, 2022)2303234
12-9072405-C-G not specified Uncertain significance (Sep 30, 2021)2252771
12-9072429-C-T not specified Uncertain significance (Oct 18, 2021)3078885
12-9072799-G-T not specified Uncertain significance (Nov 10, 2022)2230211
12-9074556-C-T Benign (Oct 17, 2017)713107
12-9074642-G-A not specified Uncertain significance (May 30, 2023)2521978
12-9074660-G-T not specified Uncertain significance (Dec 30, 2023)3078057
12-9074663-G-A not specified Uncertain significance (Nov 07, 2023)3077670
12-9074723-T-A not specified Uncertain significance (Dec 21, 2021)2268524
12-9076794-T-C A2M-related disorder Likely benign (Feb 15, 2022)3058150
12-9076800-C-G not specified Uncertain significance (Feb 28, 2024)3076781
12-9076803-T-C A2M-related disorder Likely benign (Oct 08, 2019)3046130
12-9076832-A-G Benign (Dec 04, 2017)781242
12-9076903-C-T not specified Uncertain significance (Jan 06, 2023)2474181
12-9077348-T-G not specified Uncertain significance (Apr 17, 2024)3261780
12-9077398-G-T not specified Uncertain significance (Dec 05, 2022)2332459
12-9077429-A-C A2M-related disorder Likely benign (May 25, 2023)3057128
12-9079271-C-T A2M-related disorder Likely benign (Jul 10, 2018)711716

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
A2Mprotein_codingprotein_codingENST00000318602 3648566
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
4.52e-111.001256561911257480.000366
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.876277730.8110.00004049524
Missense in Polyphen109167.80.64962089
Synonymous1.652693060.8800.00001702896
Loss of Function4.903279.00.4050.00000403963

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.001120.00109
Ashkenazi Jewish0.0001080.0000992
East Asian0.0001090.000109
Finnish0.00009280.0000924
European (Non-Finnish)0.0004750.000457
Middle Eastern0.0001090.000109
South Asian0.0002970.000294
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Is able to inhibit all four classes of proteinases by a unique 'trapping' mechanism. This protein has a peptide stretch, called the 'bait region' which contains specific cleavage sites for different proteinases. When a proteinase cleaves the bait region, a conformational change is induced in the protein which traps the proteinase. The entrapped enzyme remains active against low molecular weight substrates (activity against high molecular weight substrates is greatly reduced). Following cleavage in the bait region, a thioester bond is hydrolyzed and mediates the covalent binding of the protein to the proteinase.;
Pathway
Complement and coagulation cascades - Homo sapiens (human);Human Complement System;Dengue-2 Interactions with Complement and Coagulation Cascades;Complement and Coagulation Cascades;Signal Transduction;HDL assembly;Plasma lipoprotein assembly;Extracellular matrix organization;Rho GTPase cycle;Transport of small molecules;Platelet degranulation ;Response to elevated platelet cytosolic Ca2+;Platelet activation, signaling and aggregation;Signaling by Rho GTPases;Intrinsic Pathway of Fibrin Clot Formation;Hemostasis;Degradation of the extracellular matrix;Formation of Fibrin Clot (Clotting Cascade);Plasma lipoprotein assembly, remodeling, and clearance;IL6-mediated signaling events (Consensus)

Recessive Scores

pRec
0.796

Intolerance Scores

loftool
0.944
rvis_EVS
0.1
rvis_percentile_EVS
60.76

Haploinsufficiency Scores

pHI
0.270
hipred
N
hipred_score
0.319
ghis
0.515

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.930

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
A2m
Phenotype

Gene ontology

Biological process
negative regulation of complement activation, lectin pathway;platelet degranulation;blood coagulation, intrinsic pathway;negative regulation of endopeptidase activity;extracellular matrix disassembly;positive regulation of GTPase activity;stem cell differentiation;regulation of small GTPase mediated signal transduction
Cellular component
extracellular region;cytosol;platelet alpha granule lumen;collagen-containing extracellular matrix;extracellular exosome;blood microparticle
Molecular function
protease binding;serine-type endopeptidase inhibitor activity;GTPase activator activity;signaling receptor binding;protein binding;growth factor binding;enzyme binding;interleukin-8 binding;interleukin-1 binding;tumor necrosis factor binding;calcium-dependent protein binding